期刊文献+

涎腺多形性腺瘤中雌激素受体和P53蛋白的表达相关关系的研究

RELATIONSHIP BETWEEN EXPRESSIONS OF ER AND P53 PROTEIN IN HUMAN MIXED TUMOR
下载PDF
导出
摘要 [目的]探讨ER和P53蛋白表达与涎腺多形性腺瘤的临床病理关系。[方法]应用免疫组织化学方法检测多形性腺瘤中ER和P53蛋白的表达。[结果]在40例多形性腺瘤中,ER阳性者16例,表达率为40%(16/40);P53蛋白表达22例,其表达率为55%(22/40);ER阳性的P53蛋白阳性表达率高于ER阴性,具有统计学差异。[结论]ER阳性的多形性腺瘤与P53蛋白表达密切相关。ER和P53蛋白的表达与多形性腺瘤的预后(复发、恶变)密切相关。 [Objective] To ascertain clinical pathological relationship between distribution of estrogen receptor (ER), p53 protein accumulation and mixed tumor. [Methods] Depressions of ER and p53 protein were detected by immanohistochemistry method. [Results] ER was identified in 16 eases of 40 patients with mixed tumor. The positive rate was 40%. P53 protein was seen in 22 cases. It's positive rate was 55%. ER positive cases had a significantly higher expression of p53 protein than ER negative cases, [Conclusions] The results demonstrates a consistent relationship between ER and p53 protein accumulation. And ER, P53 protein accumulation have eolse relation to prognosis of mixed trmor.
出处 《现代预防医学》 CAS 北大核心 2007年第8期1450-1450,1460,共2页 Modern Preventive Medicine
关键词 多形性腺瘤 免疫组化 雌激素受体 P53蛋白 预后 Mixed tumor. Immunohistochemistrv: ER, D53 Protein Proanosis
  • 相关文献

参考文献3

二级参考文献12

  • 1郑麟藩.口腔病理学[M].上海:上海科技出版社,1994,11..
  • 2Li XM,Tang ZY,Zhou G,et al. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma. J Exp Clin Cancer Res,1998,17(5) :13-17.
  • 3Adachi E,Metsumata T,Nishizaki T,et al. Effects of preoperative hepatic artery chemoembolization for hepatocellular carcinoma.The relationship between postoperative course and tumor necrosis. Cancer,1993,72(9) :3593-3598.
  • 4Kobayashi N,Ishii M,Ueno Y,et al. Co-expression of bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemombolization. Liver, 1999,19(1) : 25-31.
  • 5Kunio S,Norio H, Yasuhide M,et al. Expression of vascular permeability/Vascular Endotheial Growth Factor in human hepatocellular carcinoma. Cancer Res, 1996,56(12) : 3004-3009.
  • 6Baccala A, Zhong H, Cliff SM, et al. Serum vascular endothelial growth factor is a candidate biomarker of metastati tumor response of renal cell cancer. Urology,1998,51(10):327-332.
  • 7Jin-no K, Tanimizu M, Hyodo I, et al. Circulating vascular endothelial growth factor is a possible tumor marker for metastasis in human hepatocellular carcinoma. J Gastroenterol,1998,33(5) :376-382.
  • 8Nagasue N,Galizia G,Kohno H.et al. Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma aretrospective comparision of 138 liver resection.Surgery, 1998,106(2) :81-86.
  • 9Minchenko A,Bauer T, Salceda S, et al. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and vivo.Lab Invest,1994,71(5) :374-379.
  • 10刘永锋.肝动脉化疗栓塞术在肝癌治疗中的作用和地位[J].中国实用外科杂志,1999,19(11):696-703. 被引量:11

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部